Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:319569OMIM:209950D84.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency is a rare inherited immune disorder that makes a person unusually vulnerable to infections caused by mycobacteria. Mycobacteria are a group of germs that include the bacteria causing tuberculosis (TB) and a related group called nontuberculous mycobacteria (NTM), which are normally harmless to most people. In this condition, the body's immune defense is weakened because the receptor for interferon-gamma (a key immune signaling molecule) does not work properly. Because the deficiency is only partial, the receptor still has some function, which generally leads to a less severe form of the disease compared to complete deficiency. People with this condition typically develop recurrent or severe infections with mycobacteria, often starting in childhood. These infections can affect the lymph nodes, lungs, bones, skin, and sometimes spread throughout the body (disseminated infection). Patients may also be more susceptible to certain other infections, including Salmonella bacteria and some fungi. Symptoms often include persistent fevers, swollen lymph nodes, chronic cough, weight loss, and poor growth in children. Treatment usually involves long-term antibiotic therapy targeted at the specific mycobacterial infection. In some cases, supplemental interferon-gamma therapy (Actimmune, or interferon gamma-1b) may be used to boost the immune response. Early diagnosis and ongoing management by immunology specialists are important for improving outcomes. While the partial deficiency generally carries a better prognosis than complete deficiency, lifelong vigilance against infections is necessary.

Also known as:

Key symptoms:

Recurrent or severe infections with mycobacteria (including tuberculosis-like germs)Swollen lymph nodes that may drain or form abscessesPersistent or recurring feversChronic coughWeight loss or failure to thrive in childrenPoor growthBone infections (osteomyelitis)Skin lesions or sores that do not heal easilyLung infections that keep coming backInfections that spread throughout the body (disseminated infections)Salmonella infectionsFatigue and general weaknessNight sweats

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency.

View clinical trials →

No actively recruiting trials found for Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency community →

No specialists are currently listed for Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiencyForum →

No community posts yet. Be the first to share your experience with Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency.

Start the conversation →

Latest news about Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency

No recent news articles for Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my child's (or my) IFNgammaR1 deficiency, and what does that mean for infection risk?,What infections should we watch for, and what are the early warning signs?,Will my child need lifelong antibiotic treatment?,Is interferon-gamma therapy recommended in our case, and what are the side effects?,Are there any vaccines that should be avoided?,Should other family members be tested for this genetic condition?,What precautions should we take at home, school, or work to reduce infection risk?

Common questions about Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency

What is Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency?

Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency is a rare inherited immune disorder that makes a person unusually vulnerable to infections caused by mycobacteria. Mycobacteria are a group of germs that include the bacteria causing tuberculosis (TB) and a related group called nontuberculous mycobacteria (NTM), which are normally harmless to most people. In this condition, the body's immune defense is weakened because the receptor for interferon-gamma (a key immune signaling molecule) does not work properly. Because the deficiency is on

How is Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency inherited?

Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency typically begin?

Typical onset of Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency is childhood. Age of onset can vary across affected individuals.